Deans' stroke musings: MyndTec Announces Exclusive Supply and Distribution Agreement for Innovative Foot Drop FES Device MyndStep(TM) Across the US and Canada

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, August 6, 2022

MyndTec Announces Exclusive Supply and Distribution Agreement for Innovative Foot Drop FES Device MyndStep(TM) Across the US and Canada

Is this on your hospital's radar? Or are they already using another foot drop stimulator? Why would this one be better?

MyndTec Announces Exclusive Supply and Distribution Agreement for Innovative Foot Drop FES Device MyndStep(TM) Across the US and Canada

MyndStep(TM) is designed to provide functional electric stimulation (FES) treatment to patients suffering from foot drop and improve walking ability.

Highlights:

MyndTec expands its FES portfolio with new product
MyndStep^TM is intended to address foot drop ailments and improve gait
Exclusive Supply and Distribution agreement for the United States and Canada

Mississauga, Ontario--(Newsfile Corp. - August 5, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce the addition of its newest product MyndStep^TM, to its FES portfolio. MyndStep^TM addresses foot drop ailments. MyndTec has entered into a supply and distribution agreement with Guangzhou Longest Science & Technology Co. Ltd. ("GLST") for the exclusive distribution of MyndStep^TM Foot Drop device, to be available in the United States and Canada by the fourth quarter of 2022.

"We are so very pleased to announce this new product, and excited about this opportunity to further enhance our FES portfolio of products. The addition of MyndStep^TM, a lower body focused FES system for foot drop is a natural complement to our flagship upper body FES product MyndMove," said Craig Leon, CEO of MyndTec Inc. "The addition of our newest FES lower body product MyndStep^TM, reinforces our commitment to providing clinics, rehabilitation centers and physicians with innovative products focused on improving patient care and quality of life. We look forward to introducing our latest product to our existing and new customers, and more importantly, introducing patients to an innovative technology which will help them regain function and mobility and restore independence, one step at a time."

Introducing MyndStep(TM)

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8590/132978_myndstep.jpg

MyndStep^TM is intended to provide ankle dorsiflexion of the foot and/or knee flexion, also improving an individual's gait or ability to walk. MyndStep^TM prevents or retards disuse atrophy, maintains or increases joint range of motion and local blood flow.

Product Advantage and Convenience

Easy Electrode Placement: convenient electrodes with magnetic snap connection, are placed on the peroneal nerve and tibialis anterior nerve.
Wearable Design: the device is small and light, with rechargeable battery and can be worn in a cuff just below the knee.
Mobile Phone & Tablet Friendly: the MyndStep^TM device is connected to a user App, available for download on IoS and Android, and is Bluetooth enabled.
App Functionality: the mobile app allows users to control the device more intuitively, and conveniently and provides real time treatment progress for users.
Variable Treatment Modes: 1) Training Mode: to exercise the muscle and improve dorsiflexion, 2) Walking Mode: to help patients walk faster, more naturally and safely.
Electric Stimulation Intensity: is easily adjustable to suit any users preferred setting
Built-in Smart Sensors: Device has built-in sensors that can detect valid gait events and provide precise stimulation, producing a more normalized walking pattern. Users can monitor their improvement in walking pattern, distance and speed using their mobile device.
For home and outdoor use.
Available across the United States and Canada, beginning Q4 2022.